Morgan Stanley Neuro Pace Inc Transaction History

Morgan Stanley

$1.36 Trillion
Q1 2025

A detailed history of Morgan Stanley transactions in Neuro Pace Inc stock. As of the latest transaction made, Morgan Stanley holds 2,530,620 shares of NPCE stock, worth $25.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,530,620

Previous 2,491,830 1.56%

Holding current value

$25.8 Million

Previous $27.9 Million 11.54%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$10.04 - $14.94 $389,451 - $579,522	38,790 Added 1.56%	2,530,620 $31.1 Million
Q4 2024 Feb 14, 2025	SELL	$5.9 - $11.93 $14,814 - $29,956	-2,511 Reduced 0.1%	2,491,830 $27.9 Million
Q3 2024 May 14, 2025	BUY	$6.65 - $8.46 $154,273 - $196,263	23,199 Added 0.94%	2,494,341 $17.4 Million
Q3 2024 Nov 14, 2024	BUY	$6.65 - $8.46 $154,273 - $196,263	23,199 Added 0.94%	2,494,341 $17.4 Million
Q2 2024 May 14, 2025	SELL	$6.38 - $15.33 $131,989 - $317,147	-20,688 Reduced 0.83%	2,471,142 $18.7 Million
Q2 2024 Oct 17, 2024	SELL	$6.38 - $15.33 $81,925 - $196,852	-12,841 Reduced 0.52%	2,471,142 $18.7 Million
Q2 2024 Aug 14, 2024	SELL	$6.38 - $15.33 $81,925 - $196,852	-12,841 Reduced 0.52%	2,471,142 $18.7 Million
Q1 2024 Oct 17, 2024	BUY	$9.78 - $17.5 $125,584 - $224,717	12,841 Added 0.52%	2,483,983 $32.8 Million
Q1 2024 Aug 16, 2024	BUY	$9.78 - $17.5 $227,551 - $407,172	23,267 Added 0.95%	2,483,983 $32.8 Million
Q1 2024 May 15, 2024	BUY	$9.78 - $17.5 $227,551 - $407,172	23,267 Added 0.95%	2,483,983 $32.8 Million
Q4 2023 Aug 16, 2024	SELL	$5.9 - $10.31 $61,513 - $107,492	-10,426 Reduced 0.42%	2,460,716 $25.4 Million
Q4 2023 Feb 13, 2024	BUY	$5.9 - $10.31 $359,900 - $628,910	61,000 Added 2.54%	2,460,716 $25.4 Million
Q3 2023 Nov 15, 2023	BUY	$4.0 - $9.73 $163,400 - $397,470	40,850 Added 1.73%	2,399,716 $23.3 Million
Q2 2023 Aug 14, 2023	BUY	$3.98 - $5.12 $401,383 - $516,352	100,850 Added 4.47%	2,358,866 $10.6 Million
Q1 2023 May 15, 2023	BUY	$1.44 - $5.34 $99,969 - $370,718	69,423 Added 3.17%	2,258,016 $10.5 Million
Q4 2022 Feb 14, 2023	BUY	$1.29 - $3.67 $83,837 - $238,513	64,990 Added 3.06%	2,188,593 $3.26 Million
Q3 2022 Nov 14, 2022	BUY	$3.1 - $5.98 $429,083 - $827,715	138,414 Added 6.97%	2,123,603 $7.96 Million
Q2 2022 Oct 27, 2022	BUY	$4.95 - $8.7 $4.7 Million - $8.26 Million	949,405 Added 91.66%	1,985,189 $9.83 Million
Q2 2022 Aug 15, 2022	BUY	$4.95 - $8.7 $4.7 Million - $8.26 Million	949,405 Added 91.66%	1,985,189 $9.83 Million
Q1 2022 Oct 27, 2022	SELL	$7.06 - $11.57 $6.7 Million - $11 Million	-949,405 Reduced 47.82%	1,035,784 $8.5 Million
Q1 2022 May 13, 2022	BUY	$7.06 - $11.57 $5.43 Million - $8.9 Million	769,556 Added 289.06%	1,035,784 $8.5 Million
Q4 2021 Feb 14, 2022	BUY	$8.63 - $17.36 $2.23 Million - $4.49 Million	258,570 Added 3376.47%	266,228 $2.68 Million
Q3 2021 Nov 15, 2021	BUY	$15.85 - $25.07 $121,379 - $191,986	7,658 New	7,658 $121,000

Others Institutions Holding NPCE

# of Institutions

Shares Held

24.8M

Call Options Held

1.8K

Put Options Held

300

View Full List

About NeuroPace Inc

Ticker NPCE
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,846,900
Market Cap $253M
Description
NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and ena...

More about NPCE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account